sabcs: mixed results for targeted agents in breast ca
Published 14 years ago • 100 plays • Length 2:22Download video MP4
Download video MP3
Similar videos
-
2:57
sabcs: stem cells a promising target in breast ca
-
3:27
sabcs: more evidence that bisphosphonates prevent breast cancer
-
15:50
spotlight session 8 her2 positive breast cancer novel therapies for her2 advanced breast cancer
-
1:51:16
dr. bora lim | challenging types of breast cancer | sabcs 2022 | education session
-
4:45
dramatic os boost with kisqali in young breast ca patients - medpage today
-
30:57
treatment updated for her2 positive breast cancer: changing paradigms
-
3:40
mixed picture for neoadjuvant breast ca tx
-
5:27
sabcs: novel agents shine at conference
-
20:25
the predictive power of the breast cancer index (h/i) biomarker-sabcs 2022
-
28:32
dr. reuben harris | san antonio breast cancer symposium 2022 | basic science workshop
-
25:22
educational sessions: "refining axillary management after neoadjuvant chemotherapy - what does..."
-
7:56
sabcs snippets: findings on breast cancer prevention
-
3:45
sabcs: no need for anthracycline with trastuzumab
-
35:54
sabcs 2023 – evolving trends in hr , early-stage breast cancer diagnostics
-
2:24
sabcs: risk of vaginal estrogens not known in breast cancer patients
-
21:36
treatment planning for triple negative breast cancer | 2022 evolution conference
-
17:26
dr. erica mayer | san antonio breast cancer symposium 2022 | general session
-
0:32
highlights in her2-low breast cancer at sabcs 2022
-
29:57
dr. prudence francis | premenopausal er breast cancer: past, present, future | sabcs 2022
-
27:09
dr. susan dent | san antonio breast cancer symposium 2022 | educational session
-
57:48
2022 san antonio breast cancer symposium update on mbc | 2022-2023 embrace mbc virtual forum series
-
58:11
latest research on metastatic breast cancer from san antonio breast cancer symposium